Walleye Capital’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,474
| Closed | -$85.4K | – | 2338 |
|
|
2023
Q3 | $85.4K | Buy |
+15,474
| New | +$85.4K | ﹤0.01% | 1685 |
|
|
2023
Q2 | – | Sell |
-18,790
| Closed | -$173K | – | 2237 |
|
|
2023
Q1 | $173K | Sell |
18,790
-88,653
| -83% | -$815K | ﹤0.01% | 1369 |
|
|
2022
Q4 | $1.1M | Buy |
107,443
+92,899
| +639% | +$948K | 0.02% | 683 |
|
|
2022
Q3 | $214K | Buy |
+14,544
| New | +$214K | ﹤0.01% | 1447 |
|
|
2022
Q2 | – | Sell |
-97,852
| Closed | -$1.06M | – | 2371 |
|
|
2022
Q1 | $1.06M | Buy |
97,852
+32,032
| +49% | +$345K | 0.03% | 592 |
|
|
2021
Q4 | $1.07M | Buy |
65,820
+45,420
| +223% | +$741K | 0.03% | 535 |
|
|
2021
Q3 | $437 | Buy |
+20,400
| New | +$437 | 0.01% | 818 |
|